Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 6, 2011


The board of the Center for Genomic Regulation in Spain has named Luis Serrano director for an initial term of five years. He replaces Miguel Beato, who has headed the institute for the past 10 years.

Serrano currently heads the systems biology program at the Center for Genomic Regulation. He was previously group leader at the European Molecular Biology Laboratory and structural and computational biology program manager between the EMBL and the Spanish National Cancer Research Center. He holds a PhD in biochemistry from the Autonomous University of Madrid.

The National Human Genome Research Institute has appointed Paul Liu to deputy scientific director. Liu joined the NHGRI in 1993 as an intramural scientist. He leads the oncogenesis and development section within NHGRI's Genetics and Molecular Biology Branch, focusing on the genetics of acute myeloid leukemia, and the genetic control of hematopoiesis. He holds an MD from the Capital Institute of Medicine, Beijing, and a PhD in genetics from the University of Texas.

Former president of Myriad Genetics, Gregory Critchfield, has been appointed chairman of the board of directors at Saladax Biomedical. Critchfield was president of Myriad until March 2010. Previously, he was the chief medical and science officer at Corning Clinical Laboratories, which became Quest Diagnostics. He also served on the medical school faculties of the University of Minnesota, Wayne State University, and Duke University; and was the director of clinical pathology for Intermountain Health Care, a large integrated healthcare network. He has also served as an independent director in industry associations and other life science diagnostic product and platform companies, including Integrated Diagnostics, Sera Prognostics, Metamark Genetics, Nodality, Biocius Life Sciences, and BioTrove.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.